ABBOTT PARK, Ill., July 23, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple‡ smartphone devices.
Abbott Receives FDA Approval for IOS-Compatible App Allowing People with Movement Disorders to Personalize Therapy Via Their Mobile Device
Posted on July 23, 2020
Categories: In the News